A Bcr/Abl kinase antagonist for chronic myelogenous leukemia: A promising path for progress emerges

被引：20
|
作者：
Sausville, EA [1 ]
机构：
[1] NCI, Dev Therapeut Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1999年 / 91卷 / 02期
关键词：
D O I：
10.1093/jnci/91.2.102
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：102 / 103
页数：2
相关论文
共 50 条
  • [31] Decision of stabilization or degradation of Chronic myelogenous leukemia (CML) oncoprotein, BCR-ABL, via kinase domain
    Tsukahara, Fujiko
    Maru, Yoshiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 94P - 94P
  • [32] BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells
    Brauer, Katharina M.
    Werth, Daniela
    von Schwarzenberg, Karin
    Bringmann, Anita
    Kanz, Lothar
    Gruenebach, Frank
    Brossart, Peter
    CANCER RESEARCH, 2007, 67 (11) : 5489 - 5497
  • [33] Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
    Lichtman, Marshall A.
    ONCOLOGIST, 2008, 13 (06): : 645 - 654
  • [34] BCR-ABL - AN ANTI-APOPTOSIS GENE IN CHRONIC MYELOGENOUS LEUKEMIA
    COTTER, TG
    LEUKEMIA & LYMPHOMA, 1995, 18 (3-4) : 231 - 236
  • [35] RAS IS ESSENTIAL FOR TRANSFORMATION BY THE BCR-ABL ONCOGENE OF CHRONIC MYELOGENOUS LEUKEMIA
    SAWYERS, CL
    MCLAUGHLIN, J
    HAVLIK, M
    WITTE, O
    BLOOD, 1993, 82 (10) : A331 - A331
  • [36] Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL
    Breccia, Massimo
    Alimena, Giuliana
    CURRENT DRUG TARGETS, 2009, 10 (06) : 530 - 536
  • [37] Mechanism of stability and degradation of the chronic myelogenous leukemia oncoprotein, BCR-ABL
    Tsukahara, F
    Maru, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 105P - 105P
  • [38] Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more
    Cea, M.
    Cagnetta, A.
    Garuti, A.
    Cirmena, G.
    Rocco, I.
    Moran, E.
    Grillo, V.
    Ballestrero, A.
    Patrone, F.
    Nencioni, A.
    JOURNAL OF BUON, 2009, 14 (04): : 565 - 573
  • [39] ALTERNATIVE 5' END OF THE BCR-ABL TRANSCRIPT IN CHRONIC MYELOGENOUS LEUKEMIA
    ROMERO, P
    BERAN, M
    SHTALRID, M
    ANDERSSON, B
    TALPAZ, M
    BLICK, M
    ONCOGENE, 1989, 4 (01) : 93 - 98
  • [40] Detection of BCR/ABL fusion product in normoblasts in a case of chronic myelogenous leukemia
    McFarlane, R
    Sun, T
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (09) : 1240 - 1244
12345